Respiratory & Sleep Devices
Companies producing CPAP systems, ventilators, portable oxygen concentrators, and sleep diagnostic equipment.
- 5
- Verticals
Overview
Respiratory & Sleep Devices covers manufacturers of CPAP systems, ventilators, portable oxygen concentrators, and sleep-diagnostic equipment. The sleep-apnea market (ResMed, and Philips Respironics before its major device recall) is the largest piece, with the Philips recall having significantly reshaped competitive share.
Demand is driven by the high prevalence and rising diagnosis of sleep apnea and respiratory conditions, with recurring mask and supply revenue. The category is consolidated, and the GLP-1/obesity dynamic adds a long-term question for sleep-apnea volumes. It sits within broad instrument manufacturing in the federal data.
Market snapshot
Within surgical & medical instruments (NAICS 339112) and electromedical; the Census Bureau does not split out respiratory/sleep, so the segment is not separately sized.
Business model & economics
Revenue model
Devices plus recurring masks, supplies, and consumables
Key economics
- Recurring revenue
- High
- EBITDA margin
- 20–30%
- Capex intensity
- High
recurring mask and supply replacement
Characteristics
- Sleep apnea is the largest piece of the category.
- Philips recall reshaped competitive share.
- Recurring mask-and-supply consumable revenue.
M&A deal context
Who’s acquiring
- Respiratory & sleep strategics
- Diversified medtech platforms
- PE-backed device companies
What’s driving deals
- Share shifts following the Philips recall.
- Rising sleep-apnea diagnosis.
- Recurring-consumable economics.
Verticals in this segment
Find Respiratory & Sleep Devices acquisition targets
Search Acquisera’s index for companies classified under Respiratory & Sleep Devices (4.8.11) and build a targeted deal pipeline.
Search companies